Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement

George Makdisi, Peter B. Makdisi, I-Wen Wang

Research output: Contribution to journalReview article

4 Scopus citations


The superiority of transcatheter aortic valve replacement (TAVR) compared with medical therapy for patients with aortic stenosis (AS) who are not suitable candidates for surgery had been proven. Cardiopulmonary bypass (CPB) is rarely used in TAVR. Reports of early use of extracorporeal membranous oxygenator (ECMO) have promising outcomes. ECMO offers the option of cardiac support rescue in case of intraoperative hemodynamic instability and can be instituted in advance when hemodynamic instability is expected. Here we review the English literature about the use of ECMO in TAVR procedures, and discuss the indications and rationale for its use as well as its advantages.

Original languageEnglish (US)
Article number306
JournalAnnals of Translational Medicine
Issue number16
StatePublished - Aug 1 2016


  • Aortic stenosis (AS)
  • Extracorporeal membranous oxygenator (ECMO)
  • TAVI
  • Transcatheter aortic valve replacement (TAVR)

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement'. Together they form a unique fingerprint.

  • Cite this